Animal and Plant Health Inspection Service
02/18/2026 | Press release | Archived content
FDA Issues Emergency Use Authorizations for Drugs to Treat New World Screwworm in Dogs and Cats
Breadcrumb
- Home
- About
- News and Media
- News and Updates
- FDA Issues Emergency Use Authorizations for Drugs to Treat New World Screwworm in Dogs and Cats
FDA Issues Emergency Use Authorizations for Drugs to Treat New World Screwworm in Dogs and Cats
Washington, D.C., February 18, 2026- Today the U.S. Food and Drug Administration issued two Emergency Use Authorizations (EUAs) - one for NexGard (afoxolaner) chewable tablets for the treatment of New World screwworm (NWS) infestations (myiasis) in dogs, and the second for NexGard COMBO (esafoxolaner, eprinomectin, and praziquantel topical solution) for the treatment of NWS myiasis in cats.
Animal and Plant Health Inspection Service published this content on February 18, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 03, 2026 at 05:13 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]